Real-World Evidence on Treatment Retention, Safety, and Tolerability of Edaravone in Canadian Patients With Amyotrophic Lateral Sclerosis

被引：0
|
作者：
Pham, Dung [1 ]
St-Onge, Louise [1 ]
Ng, Ryan [2 ]
Neish, Calum S. [2 ]
Yap, Belinda [3 ]
Apple, Stephen [4 ]
机构：
[1] Mitsubishi Tanabe Pharma Canada Inc, Toronto, ON, Canada
[2] IQVIA Solut Canada Inc, Toronto, ON, Canada
[3] Innomar Strategies, Oakville, ON, Canada
[4] Mitsubishi Tanabe Pharma Amer, Jersey City, NJ USA
来源：
MUSCLE & NERVE | 2023年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
89
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [21] Real-world survival effectiveness of edaravone in amyotrophic lateral sclerosis: A propensity score weighted, registrybased, Canada-wide cohort study
    Hodgkinson, Victoria
    Abrahao, Agessandro
    Vyas, Manav V.
    Zinman, Lorne
    Korngut, Lawrence
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 348 - 348
  • [22] Safety and Efficacy of Edaravone in Patients with Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-analysis
    Mengxia Gao
    Lingqun Zhu
    Jingling Chang
    Tianyu Cao
    Lianying Song
    Chunli Wen
    Yi Chen
    Yudi Zhuo
    Fei Chen
    Clinical Drug Investigation, 2023, 43 : 1 - 11
  • [23] Renal function in amyotrophic lateral sclerosis patients on long-term treatment with edaravone
    Kakimoto, Asako
    Ishizaki, Masatoshi
    Ueyama, Hidetsugu
    Maeda, Yasushi
    Ueda, Mitsuharu
    MEDICINE, 2021, 100 (21) : E26127
  • [24] Real-World Evidence on Fragility Fractures and Treatment in Canadian Osteoporotic Patients
    Meilleur, Marie-Claude
    Cloutier, Martin
    Royer, Jimmy
    Krishna, Arun
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S448 - S448
  • [25] Safety and efficacy of edaravone in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis
    Anas Zakarya Nourelden
    Ibrahim Kamal
    Abdulrahman Ibrahim Hagrass
    Abdelrahman G. Tawfik
    Mahmoud M. Elhady
    Ahmed Hashem Fathallah
    Mona Muhe Eldeen Eshag
    Mohamed Sayed Zaazouee
    Neurological Sciences, 2023, 44 : 3429 - 3442
  • [26] Safety and Efficacy of Edaravone in Patients with Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-analysis
    Gao, Mengxia
    Zhu, Lingqun
    Chang, Jingling
    Cao, Tianyu
    Song, Lianying
    Wen, Chunli
    Chen, Yi
    Zhuo, Yudi
    Chen, Fei
    CLINICAL DRUG INVESTIGATION, 2023, 43 (01) : 1 - 11
  • [27] Safety and efficacy of edaravone in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis
    Nourelden, Anas Zakarya
    Kamal, Ibrahim
    Hagrass, Abdulrahman Ibrahim
    Tawfik, Abdelrahman G.
    Elhady, Mahmoud M.
    Fathallah, Ahmed Hashem
    Eshag, Mona Muhe Eldeen
    Zaazouee, Mohamed Sayed
    NEUROLOGICAL SCIENCES, 2023, 44 (10) : 3429 - 3442
  • [28] Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial
    Gold, Julian
    Rowe, Dominic B.
    Kiernan, Matthew C.
    Vucic, Steve
    Mathers, Susan
    Van Eijk, Ruben P. A.
    Nath, Avindra
    Montojo, Marta Garcia
    Norato, Gina
    Santamaria, Ulisses A.
    Rogers, Mary-Louise
    Malaspina, Andrea
    Lombardi, Vittoria
    Mehta, Puja R.
    Westeneng, Henk-Jan
    Van Den Berg, Leonard H.
    Al-Chalabi, Ammar
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2019, 20 (7-8) : 595 - 604
  • [29] Real-world Strategies to Enhance the Palatability of Coformulated Sodium Phenylbutyrate and Taurursodiol for the Treatment of Amyotrophic Lateral Sclerosis
    Shuckett, Nicole
    Wainwright, Steven
    Jason, Tracey
    Timmons, Jamie
    MUSCLE & NERVE, 2022, 66 : S35 - S35
  • [30] Oral Edaravone - Introducing a Flexible Treatment Option for Amyotrophic Lateral Sclerosis
    Pattee, Gary L.
    Genge, Angela
    Couratier, Philippe
    Lunetta, Christian
    Sobue, Gen
    Aoki, Masashi
    Yoshino, Hiide
    Jackson, Carlayne E.
    Wymer, James
    Salah, Alejandro
    Nelson, Sally
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2023, 23 (10) : 859 - 866
12345